Paid Clinical Trials in Livingston, NJ

As of August 2026, 60 paid clinical trials are recruiting in Livingston, New Jersey. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 10, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

53 clinical trials

mHealth Mindfulness With Patients With Serious Illness and Their Caregivers

for Caregiver Stress Syndrome

Sites in Livingston, New Brunswick & Monroe

Sponsor: Rutgers, The State University of New Jersey

Sex: All·Age: 21+·Accepts healthy volunteers

Code: NCT05040711·Recruiting·Listed Sep 2021

Apply to this trial

DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment

for Colorectal Neoplasms

Sites in Livingston, Belleville +10 more locations

Sponsor: Rutgers, The State University of New Jersey

Sex: All·Age: 18+

Code: NCT07158164·Phase 4·Recruiting·Listed Sep 2025

Apply to this trial

Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients

for Cytomegalovirus (CMV)

Sites in Livingston +4 more locations

Sponsor: University of California, San Francisco

Sex: All·Age: 18+

Code: NCT06798909·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer

for Hormone Receptor-Positive Breast Cancer

Drug: Tirzepatide

Sites in Livingston, Newark +5 more locations

Sponsor: Rutgers, The State University of New Jersey

Sex: All·Age: 18+

Code: NCT06518837·Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery

for Metastatic Colon Carcinoma

Sites in Livingston, Newark +8 more locations

Sponsor: Howard S. Hochster, MD

Sex: All·Age: 18+

Code: NCT05296681·Phase 2·Recruiting·Listed Mar 2022

Apply to this trial

RADIANT: Pre-op Radiation With Abemaciclib and Letrozole

for Breast Cancer

Sites in Livingston, Belleville +2 more locations

Sponsor: Mridula George, MD

Sex: Female·Age: 60+

Code: NCT06139107·Phase 1·Recruiting·Listed Nov 2023

Apply to this trial

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

for Cutaneous Melanoma, Stage II

Sites in Livingston, Piscataway +128 more locations

Sponsor: Melanoma and Skin Cancer Trials Limited

Sex: All·Age: 18+

Code: NCT03860883·Recruiting·Listed Mar 2019

Apply to this trial

Stress Hydrocortisone In Pediatric Septic Shock

for Septic Shock

Sites in Livingston +17 more locations

Sponsor: Jerry Zimmerman

Sex: All·Age: 1 Month - 17

Code: NCT03401398·Phase 3·Recruiting·Listed Jan 2018

Apply to this trial

Periprosthetic Fracture Registry (PPFx)

for Periprosthetic Fractures

Sites in Livingston, Jersey City +2 more locations

Sponsor: AO Innovation Translation Center

Sex: All·Age: 18+

Code: NCT03378557·Recruiting·Listed Dec 2017

Apply to this trial

Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer

for Colon Cancer

Drug: Bevacizumab

Sites in Livingston, Elizabeth +7 more locations

Sponsor: Rutgers, The State University of New Jersey

Sex: All·Age: 18+

Code: NCT05806931·Phase 2·Recruiting·Listed Apr 2023

Apply to this trial

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

for Endometrial Carcinoma

Sites in Livingston, Newark +325 more locations

Sponsor: National Cancer Institute (NCI)

Sex: Female·Age: 18+

Code: NCT05256225·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

for Delayed Graft Function

Sites in Livingston +29 more locations

Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT06830798·Phase 3·Recruiting·Listed Feb 2025

Apply to this trial

Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation

for Antibody-Mediated Rejection

Sites in Livingston +20 more locations

Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All·Age: 18 - 75

Code: NCT06744647·Phase 2·Recruiting·Listed Dec 2024

Apply to this trial